BPO 0.00% 0.3¢ bioprospect limited

You would think the BioProspect deal to purchase Re-Gen is a...

  1. 1,454 Posts.
    You would think the BioProspect deal to purchase Re-Gen is a sign of BPO getting confident about relevant approvals for TERMILONE and its commercial release of the product in the next year or so - all around the world - that may see the value of the company grow substantially you would think

    Hoges
 
watchlist Created with Sketch. Add BPO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.